Company page

Alpha Cognition Inc.

Alpha Cognition Inc. (Ticker: ACOG) is a public company operating in the American market with a market capitalization of approximately $150.5 million. The company focuses on developing innovative treatments for neurodegenerative diseases. Alpha Cognition is committed to advancing its research and product pipeline to address significant unmet medical needs in this field.